1. Home
  2. TLSI vs GAMB Comparison

TLSI vs GAMB Comparison

Compare TLSI & GAMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • GAMB
  • Stock Information
  • Founded
  • TLSI 2010
  • GAMB 2006
  • Country
  • TLSI United States
  • GAMB Jersey
  • Employees
  • TLSI N/A
  • GAMB N/A
  • Industry
  • TLSI Medical Specialities
  • GAMB Services-Misc. Amusement & Recreation
  • Sector
  • TLSI Health Care
  • GAMB Consumer Discretionary
  • Exchange
  • TLSI Nasdaq
  • GAMB Nasdaq
  • Market Cap
  • TLSI 244.3M
  • GAMB 273.9M
  • IPO Year
  • TLSI N/A
  • GAMB 2021
  • Fundamental
  • Price
  • TLSI $6.21
  • GAMB $5.12
  • Analyst Decision
  • TLSI Strong Buy
  • GAMB Strong Buy
  • Analyst Count
  • TLSI 3
  • GAMB 7
  • Target Price
  • TLSI $10.67
  • GAMB $11.83
  • AVG Volume (30 Days)
  • TLSI 114.0K
  • GAMB 1.2M
  • Earning Date
  • TLSI 11-13-2025
  • GAMB 11-13-2025
  • Dividend Yield
  • TLSI N/A
  • GAMB N/A
  • EPS Growth
  • TLSI N/A
  • GAMB N/A
  • EPS
  • TLSI N/A
  • GAMB 0.05
  • Revenue
  • TLSI $40,207,000.00
  • GAMB $154,519,000.00
  • Revenue This Year
  • TLSI $57.25
  • GAMB $38.41
  • Revenue Next Year
  • TLSI $54.05
  • GAMB $11.58
  • P/E Ratio
  • TLSI N/A
  • GAMB $108.08
  • Revenue Growth
  • TLSI 49.52
  • GAMB 24.21
  • 52 Week Low
  • TLSI $3.42
  • GAMB $4.60
  • 52 Week High
  • TLSI $6.36
  • GAMB $17.14
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 77.66
  • GAMB 28.12
  • Support Level
  • TLSI $3.79
  • GAMB $4.60
  • Resistance Level
  • TLSI $4.88
  • GAMB $5.08
  • Average True Range (ATR)
  • TLSI 0.47
  • GAMB 0.33
  • MACD
  • TLSI 0.17
  • GAMB -0.07
  • Stochastic Oscillator
  • TLSI 96.84
  • GAMB 20.74

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About GAMB Gambling.com Group Limited

Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casinos online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.

Share on Social Networks: